Medically managing glaucoma
Medically managing glaucomaOptometry Times Editorial Advisory Board member Leo P. Semes, OD, FAAO, sits down to talk about managing glaucoma, treatment recommendations, intraocular pressure, and new medications in treating glaucoma at Vision Expo West in Las Vegas, NV.
Targeting dry eye in glaucoma patients
Targeting dry eye in glaucoma patientsA poor ocular surface is a common condition in glaucoma patients due to the incidence of dry eye, age, and use of benzalkonium chloride (BAK). Poor compliance with glaucoma therapy can result. Use of point-of-care testing can help identify patients with a poor ocular surface and drive treatment decisions. Treatment options, including surgical, are discussed.
New concepts in diagnosis and treatmentIn the past decade, several significant advancements have been made in the arena of glaucoma diagnosis. Spectral domain optical coherence tomography (SD-OCT), newer algorithms in trend analysis of visual field studies, and combined visually evoked potential (VEP) and pattern electroretinography (ERG) studies have been the hallmarks of such recent advancements.
Tools ODs can utilize to diagnose, treat glaucomaODs must have the right tools in their toolboxes when treating glaucoma correctly, says Optometry Times board member Michael Chaglasian, OD, FAAO, at Vision Expo East in New York.
Stem cells offering faint cure possibility for glaucomaStem cell technology may soon enter the mainstream as a treatment for ocular disease, says Leo Semes, OD, FAAO, at this year’s annual SECO 2017 conference.
How oral and dental hygiene plays a role in glaucomaIn the past couple of years, there has been discussion regarding dental and oral health—specifically the oral biomicrome—as possibly having a relationship to glaucoma.
Extended depth-of-focus IOLs may provide improved visual performanceAs your patients celebrate another birthday milestone, they are again back in your chair wondering why their reading glasses mysteriously disappear when they are out exploring life or why their arms are not as long as they used to be.
Effects of concurrent use of topical, oral beta blockersRecently, I received a progress note from a glaucoma surgeon concerning a patient whom he and I share. The patient is a 58-year-old African-American female with a longstanding history of primary open-angle glaucoma.
Charting new directions in glaucoma treatmentBen Gaddie, OD, FAAO, Optometry Times Editorial Advisory Board member, noted several specific areas that were advancing to give ODs better data and better control over patient health outcomes, including: • Corneal mechanics • 24-hour IOP monitoring • New glaucoma drugs and drug delivery systems • Advancements in OCT imaging
Optometrists should get involved in national politics, says OD RNC speaker
Optometrists should get involved in national politics, says OD RNC speakerAfter speaking at last week’s Republican National Convention in Cleveland, New Mexico OD Lisa Shin says more optometrists should get involved on a national level to keep optometry’s agenda at the forefront.